Recycling senescent cell lipids for targeted senotherapy.

Area of Science:

• Biomedical Engineering
• Osteoarthritis Research
• Cellular Senescence

Background:

• Senescent cells (SnCs) contribute to osteoarthritis (OA) pathogenesis.
• Conventional senolytic strategies for OA face limitations.
• SnCs exhibit unique lipid metabolic signatures.

Purpose of the Study:

• To develop a novel senotherapeutic strategy targeting the lipid metabolism of SnCs in OA.
• To engineer an injectable nanoliposuction hydrogel platform for lipid management in OA.

Main Methods:

• Development of an injectable nanoliposuction hydrogel.
• Exploitation of SnCs' lipid accumulation for therapeutic benefit.
• Integration of harvested lipids into a biomimetic lubricating system.

Main Results:

• The hydrogel platform effectively removes excess lipids from SnCs.
• Lipid removal mitigates the senescence-associated secretory phenotype (SASP).
• Incorporated lipids improved joint lubrication, alleviating mechanical allodynia and cartilage wear.

Conclusions:

• This strategy offers a novel approach to OA therapy by repurposing SnCs' lipids.
• The nanoliposuction hydrogel provides a senotherapeutic intervention with reduced side effects.
• Findings shift OA senescence therapy from ablation to metabolite reallocation.